TNF and inflammatory bowel disease: Combination was associated with a significant decrease in treatment ineffectiveness—unplanned IBD-related hospitalization, IBD-related resective surgery, new/recurrent corticosteroid use, or anti-TNF switch [CD: adjusted hazard ratio (aHR) 0.77, 95% CI 0.66–0.90; UC: aHR 0.72, 95% CI 0.62–0.84].